Huang Jin-Hua, Gu Yang-Kui, Fan Wei-Jun, Zhang Fu-Jun, Wu Pei-Hong
Department of Imaging & Interventional Radiology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong 510060, P. R. China.
Ai Zheng. 2005 Jun;24(6):718-21.
BACKGROUND & OBJECTIVE: Pneumothorax, usually pure pneumothorax, often occurs during interventional procedures (such as biopsy and percutaneous lung cancer radiofrequency ablation) applied in cancer patients. Traditional treatment of pneumothorax uses a thoracic drainage tube connected to an underwater seal device, and patient needs hospitalization for its huge trauma. Heimlich valve has been used in thoracic drainage for years abroad. This study was to investigate the clinical value of Heimlich valve drainage for interventional procedure-induced pneumothorax in cancer patients.
Heimlich valve connected to a chest catheter was used in treating interventional procedure-induced pneumothorax in 13 cancer patients from Mar. 1999 to Feb. 2003.
Of the 13 patients, 6 accepted inpatient management, and 7 accepted outpatient management. The pneumothoraxes of all patients were disappeared 2-3 days after drainage, and the lungs were re-expanded well. No complications occurred.
Heimlich valve pneumothorax drainage is micro-invasive, easy to perform, and safe, and can be managed in outpatient. It also can achieve good clinical results, and should be recommended when pneumothorax occurs during interventional procedure.
气胸,通常为单纯性气胸,常在癌症患者接受介入操作(如活检及经皮肺癌射频消融术)期间发生。传统的气胸治疗方法是使用连接水封装置的胸腔引流管,该方法创伤大,患者需要住院治疗。Heimlich瓣膜在国外已用于胸腔引流多年。本研究旨在探讨Heimlich瓣膜引流在癌症患者介入操作所致气胸中的临床价值。
1999年3月至2003年2月,采用连接胸导管的Heimlich瓣膜治疗13例癌症患者介入操作所致气胸。
13例患者中,6例接受住院治疗,7例接受门诊治疗。所有患者引流后2 - 3天气胸消失,肺复张良好,无并发症发生。
Heimlich瓣膜气胸引流术微创、操作简便、安全,可在门诊进行,临床效果良好,介入操作期间发生气胸时应推荐使用。